The Medical Equipment & Supplies company created some great surprise for the stock market, posting a genuine rise in fourth quarter of 2022 financial report with operating deficit of $-8.322 millions

The Medical Equipment & Supplies sector veterans begin to digest the fourth quarter of 2022 performance. Presently those veterans follow operating deficit of $-8.322 millions, from the BTTX, as it has not mentioned any revenue still, for the own October to December 31 2022 reporting season.

Better Therapeutics Inc Customers

Better Therapeutics Inc rise Rates, Profitability, PE

For the fiscal span closing December 31 2022 company decreased a loss per share of $-0.84 per share compare to $-1.28 a year prior and Income per Share improved from $-1.50 per share from the previous financial reporting period.

Revenues remained unaltered to $0.00 millions from $3.67 millions in the similar financial reporting period a year prior and sequentially Revenues surged from $0.00 millions.

Aptevo Therapeutics Inc Competitors, Market Share

Aptevo Therapeutics Inc Income Statement, Balance sheets, Cash Flow Statement

Considering the fiscal interval ending December 31 2022 Candel Therapeutics Inc Diminishing Returns have swelled at $-0.15 per share, relative to the recent numbers of $1.54 per share a year before financial reporting period, In the prior financial reporting period the Biotechnology & Pharmaceuticals company realized $-0.30 per share.

Candel Therapeutics Inc Suppliers

Candel Therapeutics Inc Suppliers

In the financial fourth quarter of 2022 company reached 0 at $0.00 per share, opposite of $0.00 per share a year ago reporting period, In the prior reporting period Invesco Db G10 Currency Harvest Fund realized $0.00 per share.

Invesco Db G10 Currency Harvest Fund Competitors, Market Share

Invesco Db G10 Currency Harvest Fund Suppliers

Deficit Despite of Revenues improvement at in the fiscal fourth quarter of 2022

For the fiscal fourth quarter of 2022 CMCT Losses have extended of $-0.39 per share compare to $-0.38 a year ago and earnings per share improved from $-0.50 per share from the previous reporting season.

Revenue grew barely by 2.957 % to $25.87 millions from $25.13 millions in the similar reporting season a year ago and sequentially Revenues surged by 4.084 % from $24.85 millions.

Creative Media And Community Trust Corporation Competitors, Market Share

Creative Media And Community Trust Corporation Suppliers

Profitability not reached inspite of astonishing Revenues at in the fourth quarter of 2022

For the fourth quarter of 2022 company lost money of $-0.04 per share compare to $-0.08 a year ago and from $-0.04 per share from the previous reporting period.

Revenues inched up substantially by 16.316 % to $2.15 millions from $1.85 millions in the same reporting period a year ago and sequentially Revenues advanced by 3.909 % from $2.07 millions.

Aspira Women S Health Inc stock quotes, charts, profile

Aspira Women S Health Inc Revenue rise Rates

Income per Share Drops at the Quaint Oak Bancorp Inc over the fiscal fourth quarter of 2022

For the fiscal fourth quarter of 2022 QNTO EPS plummeted by -44.5 % of $0.55 per share compare to $0.99 a year ago and profit plummeted by -55.19 % from $1.22 per share from the preceding quarter.

Revenues depreciated by -6.343 % to $8.80 millions from $9.40 millions in the comparable quarter a year ago and sequentially Revenues fell by -26.514 % from $11.98 millions.

Quaint Oak Bancorp Inc stock quotes, charts, profile

Quaint Oak Bancorp Inc elevation Rates, Profitability, PE

EPS Drops due to Weak Sales at the SCKT in the fourth quarter of 2022

In the October to December 31 2022 SCKT declared soft top and bottom-line, where reached zero gain and revenue by -15.427 % year on year. Revenue were to $5.17 millions compared to $6.11 millions eps at $0.00 in contrast to $0.09 in the same three months a year before.

Socket Mobile Inc Competitors, Market Share

Socket Mobile Inc Suppliers

The company declared operating loss in the fourth quarter of 2022

The investors haven't hoped for any modifications at the business during the the October to December 31 2022 reporting cycle at the company. However, they observe BTTXs' operating loss that was at $-8.322 millions, during the matching time.

Better Therapeutics Inc Competitors, Market Share

Better Therapeutics Inc Suppliers

For the fiscal interval ending December 31 2022 Aptevo Therapeutics Inc decreased a loss per share of $-0.84 per share compare to $-1.28 a year prior and EPS improved from $-1.50 per share from the previous financial reporting period.

Revenues remained unchanged to $0.00 millions from $3.67 millions in the corresponding financial reporting period a year prior and sequentially Revenues surged from $0.00 millions.

Aptevo Therapeutics Inc Suppliers

Aptevo Therapeutics Inc Income Statement, Balance sheets, Cash Flow Statement

Concentrating on the most recent fiscal period the Biotechnology & Pharmaceuticals company Losses have swelled at $-0.15 per share, relative to the results of $1.54 per share a year prior quarter, In the previous quarter the Candel Therapeutics Inc realized $-0.30 per share.

Candel Therapeutics Inc Competitors, Market Share

Candel Therapeutics Inc Income Statement, Balance sheets, Cash Flow Statement

In the fourth quarter of 2022 financial report DBV reached balanced books at $0.00 per share, opposite of $0.00 per share a year before reporting season, In the preceding reporting season The company realized $0.00 per share.

Invesco Db G10 Currency Harvest Fund Suppliers

Invesco Db G10 Currency Harvest Fund elevation Rates, Profitability, PE

The company declared a frugal improvement , during the fourth quarter of 2022 earnings season

For the October to December 31 2022 time-frame Galaxy Gaming Inc realized a shortfall per share of $0.00 in proportion to $0.02 a year ago, while Revenues advanced by 4.764 % to $5.94 millions from the same financial reporting period a year ago.

Galaxy Gaming Inc Customers

Galaxy Gaming Inc Income Statement, Balance sheets, Cash Flow Statement